---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : BT474 breast cancer cell line
treatment : 0.1 uM Lapatinib
effect    : inhibiting
hours     : 2

control   :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181633
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181634
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181635
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181636

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : BT474 breast cancer cell line
treatment : 1 uM Lapatinib
effect    : inhibiting
hours     : 2

control   :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181633
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181634
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181635
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181639

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : BT474 breast cancer cell line
treatment : 0.1 uM Lapatinib
effect    : inhibiting
hours     : 6

control   :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181633
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181634
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181635
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181637

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : BT474 breast cancer cell line
treatment : 1 uM Lapatinib
effect    : inhibiting
hours     : 6

control   :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181633
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181634
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181635
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181640

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : BT474 breast cancer cell line
treatment : 0.1 uM Lapatinib
effect    : inhibiting
hours     : 12

control   :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181633
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181634
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181635
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181638

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : BT474 breast cancer cell line
treatment : 1 uM Lapatinib
effect    : inhibiting
hours     : 12

control   :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181633
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181634
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181635
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181641

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : SKBR3 breast cancer cell line
treatment : 0.1 uM Lapatinib
effect    : inhibiting
hours     : 2

control   :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181668
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181642
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181643
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181644

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : SKBR3 breast cancer cell line
treatment : 1 uM Lapatinib
effect    : inhibiting
hours     : 2

control   :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181668
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181642
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181643
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181647

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : SKBR3 breast cancer cell line
treatment : 0.1 uM Lapatinib
effect    : inhibiting
hours     : 6

control   :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181668
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181642
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181643
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181645

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : SKBR3 breast cancer cell line
treatment : 1 uM Lapatinib
effect    : inhibiting
hours     : 6

control   :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181668
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181642
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181643
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181648

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : SKBR3 breast cancer cell line
treatment : 0.1 uM Lapatinib
effect    : inhibiting
hours     : 12

control   :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181668
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181642
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181643
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181646

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : SKBR3 breast cancer cell line
treatment : 1 uM Lapatinib
effect    : inhibiting
hours     : 12

control   :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181668
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181642
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181643
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181649

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : MDA468 breast cancer cell line
treatment : 0.1 uM Lapatinib
effect    : inhibiting
hours     : 2

control   :
    - Homo sapiens
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181651
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181652
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181653

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : MDA468 breast cancer cell line
treatment : 1 uM Lapatinib
effect    : inhibiting
hours     : 2

control   :
    - Homo sapiens
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181651
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181652
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181656

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : MDA468 breast cancer cell line
treatment : 0.1 uM Lapatinib
effect    : inhibiting
hours     : 6

control   :
    - Homo sapiens
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181651
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181652
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181654

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : MDA468 breast cancer cell line
treatment : 1 uM Lapatinib
effect    : inhibiting
hours     : 6

control   :
    - Homo sapiens
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181651
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181652
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181657

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : MDA468 breast cancer cell line
treatment : 0.1 uM Lapatinib
effect    : inhibiting
hours     : 12

control   :
    - Homo sapiens
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181651
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181652
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181655

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : MDA468 breast cancer cell line
treatment : 1 uM Lapatinib
effect    : inhibiting
hours     : 12

control   :
    - Homo sapiens
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181651
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181652
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181658

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : T47D breast cancer cell line
treatment : 0.1 uM Lapatinib
effect    : inhibiting
hours     : 2

control   :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181659
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181660
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181661
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181662

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : T47D breast cancer cell line
treatment : 1 uM Lapatinib
effect    : inhibiting
hours     : 2

control   :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181659
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181660
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181661
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181665

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : T47D breast cancer cell line
treatment : 0.1 uM Lapatinib
effect    : inhibiting
hours     : 6

control   :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181659
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181660
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181661
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181663

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : T47D breast cancer cell line
treatment : 1 uM Lapatinib
effect    : inhibiting
hours     : 6

control   :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181659
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181660
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181661
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181666

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : T47D breast cancer cell line
treatment : 0.1 uM Lapatinib
effect    : inhibiting
hours     : 12

control   :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181659
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181660
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181661
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181664

---
accession : E-MEXP-440
platform  : A-AFFY-33
pathway   : EGFR
cells     : T47D breast cancer cell line
treatment : 1 uM Lapatinib
effect    : inhibiting
hours     : 12

control   :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181659
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181660
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181661
treatment :
    - Homo sapiens__ebi.ac.uk:MIAMExpress:BioSource:181667
...
